BEAT
HeartBeam, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.43
−1.07%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$0.44
From 52W high−87.63%
Volume379287.00
Market cap$23.98M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataNov 4, 2026
Open
$0.44
From 52W high
−87.63%
Volume
379287.00
Market cap
$23.98M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.8x
P/E (TTM)
—
RSI (14)
48.2
MomentumView details →
1D Return
−1.07%
YTD Return
−82.02%
SummaryUpdated Jun 1, 2026
HeartBeam, Inc. (NASDAQ:BEAT) is a medical technology company founded in 2015 and headquartered in Santa Clara, California. The company went public in November 2021 and focuses on developing innovative telemedicine solutions for cardiac monitoring and diagnosis outside traditional healthcare facility settings. HeartBeam has developed proprietary technology that enables the creation of a credit card-sized, cable-free electrocardiogram (ECG) device capable of synthesizing a full 12-lead ECG reading, representing a significant advancement in portable cardiac monitoring technology.
Similar companies
Latest newsMore news →
HeartBeam, Inc. announced positive pilot study results showing its patient-recorded 3D ECG was as accurate as a standard 12-lead ECG for detecting heart attacks.2d agoHeartBeam, Inc. announced that it will present results of the ALIGN-ACS study at Cardiovascular Research Foundation 2026 on November 1, 2026.7d agoHeartBeam, Inc. joined the European EXIT-CVD research consortium to advance at-home ECG monitoring for early detection of acute coronary syndrome in high-risk patients.20d ago